179 related articles for article (PubMed ID: 28188435)
21. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
22. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis.
Sakhaee K; Poindexter JR; Pak CY
J Urol; 1989 Apr; 141(4):819-21. PubMed ID: 2926871
[TBL] [Abstract][Full Text] [Related]
23. Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.
Wang Y; Sun C; Li C; Deng Y; Zeng G; Tao Z; Wang X; Guan X; Zhao Y
Urolithiasis; 2017 Apr; 45(2):159-175. PubMed ID: 27393275
[TBL] [Abstract][Full Text] [Related]
24. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list.
Hess B; Michel R; Takkinen R; Ackermann D; Jaeger P
Nephrol Dial Transplant; 1994; 9(6):642-9. PubMed ID: 7970090
[TBL] [Abstract][Full Text] [Related]
26. [Hypercalciuria and primary hyperparathyroidism in patients with kidney calculi. I. Hypercalciuria].
Nieszporek T; Kokot F; Skrzypek J; Wieczorek M; Kuska J
Pol Arch Med Wewn; 1992 Jan; 87(1):41-8. PubMed ID: 1641363
[TBL] [Abstract][Full Text] [Related]
27. Lime powder treatment reduces urinary excretion of total protein and transferrin but increases uromodulin excretion in patients with urolithiasis.
Tosukhowong P; Kulpradit P; Chaiyarit S; Ungjareonwattana W; Kalpongnukul N; Ratchanon S; Thongboonkerd V
Urolithiasis; 2018 Jun; 46(3):257-264. PubMed ID: 28585182
[TBL] [Abstract][Full Text] [Related]
28. Frequency of renal phosphate leak among patients with calcium nephrolithiasis.
Prié D; Ravery V; Boccon-Gibod L; Friedlander G
Kidney Int; 2001 Jul; 60(1):272-6. PubMed ID: 11422761
[TBL] [Abstract][Full Text] [Related]
29. Cystatin C, Neutrophil Gelatinase-associated Lipocalin, and Lysozyme C: Urinary Biomarkers for Detection of Early Kidney Dysfunction in Children With Urolithiasis.
Kovacevic L; Lu H; Kovacevic N; Thomas R; Lakshmanan Y
Urology; 2020 Sep; 143():221-226. PubMed ID: 32505622
[TBL] [Abstract][Full Text] [Related]
30. Effects of short and long-term indapamide treatments on urinary calcium excretion in patients with calcium oxalate dihydrate urinary stone disease: a pilot study.
Alonso D; Pieras E; Pizá P; Grases F; Prieto RM
Scand J Urol Nephrol; 2012 Apr; 46(2):97-101. PubMed ID: 22251010
[TBL] [Abstract][Full Text] [Related]
31. Dietary style and acid load in an Italian population of calcium kidney stone formers.
Vezzoli G; Dogliotti E; Terranegra A; Arcidiacono T; Macrina L; Tavecchia M; Pivari F; Mingione A; Brasacchio C; Nouvenne A; Meschi T; Cusi D; Spotti D; Montanari E; Soldati L
Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):588-93. PubMed ID: 25921845
[TBL] [Abstract][Full Text] [Related]
32. [Importance of dietary sodium in the hypercalciuria syndrome and nephrolithiasis].
Gołabek B; Słownik M; Grabowski M
Pol Merkur Lekarski; 2000 Apr; 8(46):174-7. PubMed ID: 10897599
[TBL] [Abstract][Full Text] [Related]
33. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
[TBL] [Abstract][Full Text] [Related]
34. Hypercalciuria and stones.
Lemann J; Worcester EM; Gray RW
Am J Kidney Dis; 1991 Apr; 17(4):386-91. PubMed ID: 2008904
[TBL] [Abstract][Full Text] [Related]
35. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
Lagemann M; Anders D; Graef V; Bödeker RH
Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
[TBL] [Abstract][Full Text] [Related]
36. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
Arrabal-Martin M; Poyatos-Andujar A; Cano-García Mdel C; Quesada-Charneco M; Abad-Menor F; Girón Prieto MS; de Haro Muñoz T; Arrabal-Polo MA
Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
[TBL] [Abstract][Full Text] [Related]
37. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
[TBL] [Abstract][Full Text] [Related]
38. Urinary citrate excretion in idiopathic nephrolithiasis.
Ratan SK; Bhatnagar V; Mitra DK; Basu N; Malhotra LK
Indian Pediatr; 2002 Sep; 39(9):819-25. PubMed ID: 12368525
[TBL] [Abstract][Full Text] [Related]
39. [Influence of dietary animal protein on renal stone disease].
Katoh Y
Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):823-31. PubMed ID: 2552215
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D, Hypercalciuria and Kidney Stones.
Letavernier E; Daudon M
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]